SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 12, 2013
Delaware 000-6658 04-2217279 ___________ ____________ __________________ (State or other (Commission (IRS Employer No.) jurisdiction of File Number) incorporation) |
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
The Company has agreed to a one-year extension through December 31, 2014 of the Fifth Amended and Restated Consulting Agreement with Laboratory Innovation Company, Ltd., an affiliate of Joseph G. Cremonese, Chairman of the Board of Directors, and Mr. Cremonese on the same terms as the Fifth Amended and Restated Consulting Agreement, except that, the compensation will be increased to $3,600 per month subject to an increase or decrease in the event services are more than 60 days during the 12 month period at the guaranteed rate of $660 per day. Either the Company or the Consultant may terminate the Agreement, except for their confidentiality and non-competition covenants on at least 60 days prior notice.
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS
At the Annual Meeting of Stockholders of the Company held on December 4, 2013, the stockholders took the following actions:
1. Elected Ms. Grace P. Morin as Class B Director to serve until the Annual Meeting of Stockholders for the year ended June 30, 2016 by the following votes:
For Withheld
Grace S. Morin 631,023 22,874
2. Approved by a vote of 828,035 shares for, 24,622 shares against and 15,334 shares abstaining, and 316,095 shares of Broker non-votes the appointment by the Board of Directors of Nussbaum Yates Berg Klein & Wolpow, LLP as the Company's independent registered public accounting firm with respect to the Company's financial statements for the year ending June 30, 2014.
ITEM 9.01 Financial Statements and Exhibits
(a) and (b) not applicable
(c) Exhibits Exhibit No. Exhibit ___________ _____________________________ 10A-1 Copy of Extension Agreement between the Company and the Consultant |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
SCIENTIFIC INDUSTRIES, INC.
(Registrant)
Date: December 12, 2013 By: /s/ Helena R. Santos __________________________________ Helena R. Santos, President and Chief Executive Officer Officer |
FURTHER EXTENSION AGREEMENT
Scientific Industries, Inc., a Delaware corporation
(the "Company"), and Joseph G.
Cremonese and Laboratory Innovations Company, Ltd, (collectively,
the "Consultant") do hereby agree that the engagement of the Consultant
by the Company pursuant to the Fifth Amended and Restated Consultant
Agreement, dated January 20, 2012, as extended by the Extension Agreement
dated November 29, 2012 (the "Restatement") shall be extended through
December 31, 2014 on the same terms as the Restatement except that the
compensation of $3,300 per month is increased commencing January 1, 2014
to $3,600 per month..
Dated: December 12, 2013
SCIENTIFIC INDUSTRIES, INC.
By: /s/ Helena R. Santos Helena R. Santos, President |
JOSEPH G. CREMONESE
/s/ Joseph G. Cremonese LABORATORY INNOVATIONS COMPANY, LTD By: /s/Joseph G. Cremonese Joseph G. Cremonese |